| Literature DB >> 34718959 |
Shann S Yu1, Jeffrey A Hubbell1, Melody A Swartz2,3.
Abstract
Immunotherapies are designed to treat disease by modulating the activity of immune cells. Here, we consider how anatomy and microphysiology create transport barriers to immunotherapeutic delivery and retention at diseased sites, and summarize recent developments to overcome these barriers by exploiting immunobiology to engineer molecular and cellular engineering approaches. Creating impactful and practical solutions across these diseases requires the integration of the collective expertise of pathologists, clinicians, immunologists, biophysicists, immunoengineers, and more.Entities:
Keywords: Cellular engineering; Drug delivery; Immunoengineering; Immunotherapy; Molecular engineering; Pharmacodynamics; Pharmacokinetics
Mesh:
Year: 2021 PMID: 34718959 DOI: 10.1007/s13346-021-01084-4
Source DB: PubMed Journal: Drug Deliv Transl Res ISSN: 2190-393X Impact factor: 4.617